Molecular therapies for tuberous sclerosis and neurofibromatosis.

Molecular therapies for tuberous sclerosis and neurofibromatosis.

Item
http://www.wikidata.org/entity/Q38006431
Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysisNetwork-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epitheliumA phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KCo-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysisA Classic Case of Tuberous Sclerosis with Multisystem Involvement Including Giant Bilateral Renal Angiomyolipomas Presenting as Massive Hematuria.Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.Combining molecular targeted agents with radiation therapy for malignant gliomasAn approach to cystic kidney diseases: the clinician's view.Immune mediators in the brain and peripheral tissues in autism spectrum disorder.A Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature.Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.Epilepsy treatment: a paradigm shift is urgently need.The dynamics and power of change: changing practices in cutaneous and aesthetic surgery.Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.Neurofibromatosis Clinical Trial Consortium.
P2860

Molecular therapies for tuberous sclerosis and neurofibromatosis.

Item
http://www.wikidata.org/entity/Q38006431
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular therapies for tuberous sclerosis and neurofibromatosis.
@en
type
label
Molecular therapies for tuberous sclerosis and neurofibromatosis.
@en
prefLabel
Molecular therapies for tuberous sclerosis and neurofibromatosis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Molecular therapies for tuberous sclerosis and neurofibromatosis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698